bisphosphonate

Zoledronic Acid (ZOL 446) 是一种含氮二磷酸盐，能抑制破骨细胞的分化和凋亡，具有高效的抗骨质再吸收活性，也有抗癌作用。

Digeranyl bisphosphonate (DGBP) 是一种有效的香叶基焦磷酸香叶酯 (GGPP) 合酶抑制剂，对 Rac1 的香叶基焦磷酸化有抑制作用。Digeranyl bisphosphonate 诱导细胞发生自噬却不诱导细胞凋亡。

Aminobutane bisphosphonate is a powerful inhibitor of bone resorption. It can potentially be a useful measure for controlling hypercalcemia in patients with carcinoma.

Zoledronic acid monohydrate (CGP 42446) 是一种含氮二磷酸盐，具有高效的抗骨质再吸收活性。它能抑制破骨细胞的分化和凋亡，有抗癌作用。

BPH-1358 (NSC-50460) 是一种人 FPPS 和 UPPS 抑制剂，IC50值分别为 1.8 μM 和 110 nM，对金黄色葡萄球菌的 MIC 值大约为 250 ng/mL。

BPH-1358 (NSC50460) free base is a potent human undecaprenyl diphosphate synthase (UPPS) and farnesyl diphosphate synthase (FPPS) inhibitor (IC50s: 110 nM and 1.8 μM) and is active against S. aureus in vitro (MIC ~250 ng/mL).

Alendronic Acid (alendronate) 是法呢基二磷酸合酶(FDPS)抑制剂，是一种双膦酸盐。它能够抑制破骨细胞介导的骨吸收，对绝经后骨质疏松症，恶性高钙血症和 Paget 病具有疗效。

MBC-11 通过将阿糖胞苷和依替膦酸盐浓缩在疾病部位来靶向癌症的偶联物。MBC-11 可溶用于研究肿瘤诱发的骨病。

Pamidronate Disodium (CGP 23339A) 是一种具有强化骨骼作用的物质。

Ibandronate sodium (Boniva) 是一种高活性的含氮二磷酸盐，可用于骨质疏松的研究。

Medronic acid (Methylenediphosphonic acid) 是一种亚甲基取代的二膦酸盐。它对骨基质中的羟基磷灰石晶体的表面具有亲和力，并且可粘附在其表面。它能够在类骨质矿化的位点累积，可以在骨成像中与放射性同位素复合使用。

Alendronate sodium hydrate (MK 217) 是 farnesyl diphosphate synthase 抑制剂(IC50:460 nM)。

Clodronic acid disodium salt (Lodronate) 是一种口服具有活力的破骨细胞骨吸收 (osteoclastic bone resorption) 的抑制剂，是一代双磷酸盐。它可用于高骨转换状态、Paget’s 病和溶骨性骨转移中。

MBC-11 triethylamine has potential to treat tumor-induced bone disease (TIBD), is a first-in-class conjugate of the bone-targeting bisphosphonate etidronate covalently linked to the antimetabolite cytarabine (araC).

MBC-11 trisodium has potential to treat tumor-induced bone disease (TIBD).It is a first-in-class conjugate of the bone-targeting bisphosphonate HEDP covalently linked to the antimetabolite Ara-C.

BPH-715 抑制恶性疟原虫的肝脏阶段生长，对 HepG2 细胞中的恶性疟原虫外红细胞的形成的 IC50 为 10 μM。

Ibandronic acid (Bonviva) 是一种高效含氮双磷酸盐，可作用于骨质疏松，具有抗吸收和抗高钙血症作用。

NE 10790 (3-PEHPC) 是一种二磷酸利塞磷酸盐的磷酸酯类似物，是一种法尼焦磷酸合成酶的弱抑制剂，也是一种弱抗吸收剂。

BV600022 is an osteoadsorptive bisphosphonate-ciprofloxacin conjugate with antibacterial activity.

NE21650, a bisphosphonate, inhibits isopentenyl diphosphate isomerase and farnesyl diphosphate synthase.

Cgp 47072 is a bisphosphonate, used in the treatment of bone diseases, particularly where there is uncontrolled bone resorption.

Pamidronate monosodium is a bisphosphonate.

Tiludronate (Tiludronic Acid) disodium hemihydrate is an orally active bisphosphonate compound that functions as an osteoregulator. It is primarily utilized in metabolic bone disorder research. This compound acts as a potent inhibitor of the osteoclast vacuolar H+ -ATPase and possesses antiresorptive and anti-inflammatory properties[4].

Zoledronic Acid (Zoledronate) disodium tetrahydrate is a potent third-generation bisphosphonate (BP), exhibiting strong anti-resorptive activity. It effectively inhibits osteoclast differentiation and apoptosis, while also demonstrating anti-cancer properties [1].